Cargando…
Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study
Background. The aim of this study was to compare retrospectively the effect of three different treatment protocols on the healing outcome in patients with established medication-related osteonecrosis of the jaw (MRONJ). Methods. A total of 34 MRONJ patients were recruited from the Department databas...
Autores principales: | Tenore, Gianluca, Zimbalatti, Angela, Rocchetti, Federica, Graniero, Francesca, Gaglioti, Domenico, Mohsen, Ahmed, Caputo, Martina, Lollobrigida, Marco, Lamazza, Luca, De Biase, Alberto, Barbato, Ersilia, Romeo, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693575/ https://www.ncbi.nlm.nih.gov/pubmed/33138266 http://dx.doi.org/10.3390/jcm9113505 |
Ejemplares similares
-
The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021) -
Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study
por: Jamalpour, Mohammad Reza, et al.
Publicado: (2022) -
The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)
por: Cano-Durán, Jorge A., et al.
Publicado: (2017) -
The use of advanced‐platelet rich fibrin (A‐PRF) in the management of medication‐related osteonecrosis of the jaw (MRONJ): A case report
por: Asfour, Maan Ahmad Rafik, et al.
Publicado: (2023) -
Platelet Rich Fibrin (PRF) and Its Related Products: Biomolecular Characterization of the Liquid Fibrinogen
por: Serafini, Giorgio, et al.
Publicado: (2020)